aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
3.020
-0.110 (-3.51%)
At close: Mar 31, 2025, 4:00 PM
3.050
+0.030 (0.99%)
After-hours: Mar 31, 2025, 7:57 PM EDT
aTyr Pharma Market Cap
aTyr Pharma has a market cap or net worth of $268.35 million as of March 31, 2025. Its market cap has increased by 181.00% in one year.
Market Cap
268.35M
Enterprise Value
212.62M
1-Year Change
181.00%
Ranking
Category
Stock Price
3.02
Market Cap Chart
Since May 7, 2015, aTyr Pharma's market cap has decreased from $337.10M to $268.35M, a decrease of -20.39%. That is a compound annual growth rate of -2.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 278.10M | -8.49% |
| Dec 31, 2024 | 303.90M | 267.92% |
| Dec 29, 2023 | 82.60M | 30.08% |
| Dec 30, 2022 | 63.50M | -69.41% |
| Dec 31, 2021 | 207.60M | 428.24% |
| Dec 31, 2020 | 39.30M | 142.59% |
| Dec 31, 2019 | 16.20M | 8.72% |
| Dec 31, 2018 | 14.90M | -85.70% |
| Dec 29, 2017 | 104.20M | 104.31% |
| Dec 30, 2016 | 51.00M | -78.06% |
| Dec 31, 2015 | 232.50M | -31.03% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |